Manhattan Scientifics, Inc. (MHTX)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -7000.00 USD | 89.23% |
| 2022 | -65 Thousand USD | 36.27% |
| 2021 | -102 Thousand USD | 59.04% |
| 2020 | -249 Thousand USD | -36.07% |
| 2019 | -183 Thousand USD | -110.34% |
| 2018 | -87 Thousand USD | 67.66% |
| 2017 | -269 Thousand USD | -119.99% |
| 2016 | 1.34 Million USD | 145.08% |
| 2015 | -2.98 Million USD | -788.02% |
| 2014 | 434 Thousand USD | -78.88% |
| 2013 | 2.05 Million USD | 64.14% |
| 2012 | 1.25 Million USD | 1741.18% |
| 2011 | 68 Thousand USD | 106.65% |
| 2010 | -1.02 Million USD | -253.45% |
| 2009 | 666 Thousand USD | 44.47% |
| 2008 | 461 Thousand USD | 210.02% |
| 2007 | -419 Thousand USD | -142.62% |
| 2006 | 983 Thousand USD | -1.5% |
| 2005 | 998 Thousand USD | -43.04% |
| 2004 | 1.75 Million USD | -7.5% |
| 2003 | 1.89 Million USD | 116.7% |
| 2002 | 874 Thousand USD | 19.24% |
| 2001 | 733 Thousand USD | 177.57% |
| 2000 | -945 Thousand USD | -5.82% |
| 1999 | -893 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 9000.00 USD | 228.57% |
| 2024 Q2 | 22 Thousand USD | 144.44% |
| 2023 Q3 | -29 Thousand USD | -261.11% |
| 2023 Q1 | -20 Thousand USD | 69.23% |
| 2023 Q2 | 18 Thousand USD | 190.0% |
| 2023 Q4 | -7000.00 USD | 75.86% |
| 2023 FY | -7000.00 USD | 89.23% |
| 2022 Q1 | 14 Thousand USD | 113.73% |
| 2022 FY | -65 Thousand USD | 36.27% |
| 2022 Q3 | -149 Thousand USD | 38.68% |
| 2022 Q4 | -65 Thousand USD | 56.38% |
| 2022 Q2 | -243 Thousand USD | -1835.71% |
| 2021 Q4 | -102 Thousand USD | 57.85% |
| 2021 Q1 | -144 Thousand USD | 42.17% |
| 2021 Q2 | -335 Thousand USD | -132.64% |
| 2021 Q3 | -242 Thousand USD | 27.76% |
| 2021 FY | -102 Thousand USD | 59.04% |
| 2020 Q2 | -368 Thousand USD | -135.9% |
| 2020 FY | -249 Thousand USD | -36.07% |
| 2020 Q1 | -156 Thousand USD | 14.75% |
| 2020 Q4 | -249 Thousand USD | 33.95% |
| 2020 Q3 | -377 Thousand USD | -2.45% |
| 2019 Q3 | -144 Thousand USD | 37.39% |
| 2019 Q2 | -230 Thousand USD | -1742.86% |
| 2019 Q1 | 14 Thousand USD | 116.09% |
| 2019 FY | -183 Thousand USD | -110.34% |
| 2019 Q4 | -183 Thousand USD | -27.08% |
| 2018 Q1 | -65 Thousand USD | 75.84% |
| 2018 FY | -87 Thousand USD | 67.66% |
| 2018 Q3 | -242 Thousand USD | -86.15% |
| 2018 Q4 | -87 Thousand USD | 64.05% |
| 2018 Q2 | -130 Thousand USD | -100.0% |
| 2017 FY | -269 Thousand USD | -119.99% |
| 2017 Q4 | -269 Thousand USD | 40.49% |
| 2017 Q2 | -599 Thousand USD | 72.76% |
| 2017 Q1 | -2.19 Million USD | -263.37% |
| 2017 Q3 | -452 Thousand USD | 24.54% |
| 2016 Q1 | -1.53 Million USD | 48.69% |
| 2016 Q3 | 794 Thousand USD | 2506.06% |
| 2016 Q4 | 1.34 Million USD | 69.52% |
| 2016 FY | 1.34 Million USD | 145.08% |
| 2016 Q2 | -33 Thousand USD | 97.85% |
| 2015 Q3 | -4.39 Million USD | 21.13% |
| 2015 Q2 | -5.57 Million USD | 14.67% |
| 2015 Q1 | -6.52 Million USD | -1604.38% |
| 2015 Q4 | -2.98 Million USD | 32.04% |
| 2015 FY | -2.98 Million USD | -788.02% |
| 2014 FY | 434 Thousand USD | -78.88% |
| 2014 Q1 | 1.07 Million USD | -47.83% |
| 2014 Q2 | 1.1 Million USD | 2.89% |
| 2014 Q3 | 1.68 Million USD | 52.77% |
| 2014 Q4 | 434 Thousand USD | -74.24% |
| 2013 FY | 2.05 Million USD | 64.14% |
| 2013 Q3 | 1.87 Million USD | 138.6% |
| 2013 Q4 | 2.05 Million USD | 9.72% |
| 2013 Q2 | 785 Thousand USD | 319.79% |
| 2013 Q1 | 187 Thousand USD | -85.06% |
| 2012 Q4 | 1.25 Million USD | 42.11% |
| 2012 Q3 | 881 Thousand USD | 229.96% |
| 2012 Q2 | 267 Thousand USD | 54.34% |
| 2012 Q1 | 173 Thousand USD | 154.41% |
| 2012 FY | 1.25 Million USD | 1741.18% |
| 2011 Q4 | 68 Thousand USD | -69.91% |
| 2011 Q2 | -240 Thousand USD | 69.54% |
| 2011 Q1 | -788 Thousand USD | 22.9% |
| 2011 FY | 68 Thousand USD | 106.65% |
| 2011 Q3 | 226 Thousand USD | 194.17% |
| 2010 Q2 | 750 Thousand USD | 60.6% |
| 2010 Q4 | -1.02 Million USD | -246.21% |
| 2010 Q3 | 699 Thousand USD | -6.8% |
| 2010 FY | -1.02 Million USD | -253.45% |
| 2010 Q1 | 467 Thousand USD | -29.88% |
| 2009 Q4 | 666 Thousand USD | 65.67% |
| 2009 FY | 666 Thousand USD | 44.47% |
| 2009 Q1 | 636 Thousand USD | 37.96% |
| 2009 Q2 | 799 Thousand USD | 25.63% |
| 2009 Q3 | 402 Thousand USD | -49.69% |
| 2008 Q3 | 367 Thousand USD | -25.25% |
| 2008 Q2 | 491 Thousand USD | -35.98% |
| 2008 FY | 461 Thousand USD | 210.02% |
| 2008 Q1 | 767 Thousand USD | 283.05% |
| 2008 Q4 | 461 Thousand USD | 25.61% |
| 2007 Q1 | 1.03 Million USD | 5.39% |
| 2007 FY | -419 Thousand USD | -142.62% |
| 2007 Q4 | -419 Thousand USD | -319.37% |
| 2007 Q3 | 191 Thousand USD | 7.91% |
| 2007 Q2 | 177 Thousand USD | -82.92% |
| 2006 Q3 | 886 Thousand USD | -20.96% |
| 2006 Q4 | 983 Thousand USD | 10.95% |
| 2006 Q1 | 1.07 Million USD | 7.82% |
| 2006 Q2 | 1.12 Million USD | 4.18% |
| 2006 FY | 983 Thousand USD | -1.5% |
| 2005 Q1 | 1.67 Million USD | -4.28% |
| 2005 Q2 | 1.68 Million USD | 0.66% |
| 2005 FY | 998 Thousand USD | -43.04% |
| 2005 Q3 | 1.67 Million USD | -0.71% |
| 2005 Q4 | 998 Thousand USD | -40.45% |
| 2004 FY | 1.75 Million USD | -7.5% |
| 2004 Q3 | 1.66 Million USD | 3.54% |
| 2004 Q2 | 1.61 Million USD | 3.4% |
| 2004 Q1 | 1.55 Million USD | -17.74% |
| 2004 Q4 | 1.75 Million USD | 5.04% |
| 2003 Q1 | 768 Thousand USD | -12.13% |
| 2003 Q2 | 673 Thousand USD | -12.37% |
| 2003 FY | 1.89 Million USD | 116.7% |
| 2003 Q4 | 1.89 Million USD | 150.2% |
| 2003 Q3 | 757 Thousand USD | 12.48% |
| 2002 FY | 874 Thousand USD | 19.24% |
| 2002 Q1 | 734 Thousand USD | 0.14% |
| 2002 Q2 | 724 Thousand USD | -1.36% |
| 2002 Q3 | 690 Thousand USD | -4.7% |
| 2002 Q4 | 874 Thousand USD | 26.67% |
| 2001 Q4 | 733 Thousand USD | 7.95% |
| 2001 Q3 | 679 Thousand USD | 81.55% |
| 2001 Q1 | 94 Thousand USD | 109.95% |
| 2001 FY | 733 Thousand USD | 177.57% |
| 2001 Q2 | 374 Thousand USD | 297.87% |
| 2000 Q2 | -428 Thousand USD | 26.59% |
| 2000 Q4 | -945 Thousand USD | -1469.57% |
| 2000 Q3 | 69 Thousand USD | 116.12% |
| 2000 Q1 | -583 Thousand USD | 0.0% |
| 2000 FY | -945 Thousand USD | -5.82% |
| 1999 FY | -893 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| BioElectronics Corporation | 14.82 Million USD | 100.047% |
| Medical Supply International USA, Inc. | 216.6 Thousand USD | 103.232% |
| Polarean Imaging plc | -5.94 Million USD | 99.882% |
| Avitar, Inc. | 5.17 Million USD | 100.135% |
| CVR Medical Corp. | - USD | Infinity% |
| IR-Med Inc. | -606 Thousand USD | 98.845% |
| AVITA Medical, Inc. | -26.23 Million USD | 99.973% |
| Össur hf. | 395.08 Million USD | 100.002% |
| Zecotek Photonics Inc. | 2.76 Million USD | 100.253% |
| QHSLab, Inc. | 1.72 Million USD | 100.405% |
| Wellstar International, Inc. | 51.36 Million USD | 100.014% |
| Össur hf. | 395.08 Million USD | 100.002% |
| Bionovate Technologies Corp | - USD | Infinity% |
| EKF Diagnostics Holdings plc | -4.61 Million USD | 99.848% |
| Escalon Medical Corp. | 315.68 Thousand USD | 102.217% |
| Aurora Spine Corporation | 1.9 Million USD | 100.367% |
| BrainsWay Ltd. | -10.32 Million USD | 99.932% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| NewCardio, Inc. | 2.41 Million USD | 100.29% |
| Hamilton Thorne Ltd. | 18.12 Million USD | 100.039% |
| Vivos Inc. | -1.59 Million USD | 99.56% |
| MicroPort Scientific Corporation | 673.58 Million USD | 100.001% |
| Kelyniam Global, Inc. | 487.33 Thousand USD | 101.436% |
| REMSleep Holdings, Inc. | -540.98 Thousand USD | 98.706% |
| CYduct Diagnostics, Inc. | 640.19 Thousand USD | 101.093% |
| Nanomix Corporation | 11.38 Million USD | 100.061% |
| Theraclion SA | -5.86 Million EUR | 99.881% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Wellness Center USA, Inc. | 3.98 Million USD | 100.176% |
| Positron Corporation | 1.68 Million USD | 100.415% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | 1.61 Million USD | 100.435% |
| Lombard Medical, Inc. | 11.49 Million USD | 100.061% |
| ALR Technologies Inc. | 19.14 Million USD | 100.037% |
| Stratec SE | 119.12 Million USD | 100.006% |
| Vycor Medical, Inc. | 1.05 Million USD | 100.665% |
| Heart Tronics, Inc. | 54.99 Thousand USD | 112.728% |
| Nu-Med Plus, Inc. | 93.19 Thousand USD | 107.511% |
| Perimeter Medical Imaging AI, Inc. | -13.78 Million USD | 99.949% |
| SANUWAVE Health, Inc. | 30.14 Million USD | 100.023% |
| VMS Rehab Systems, Inc. | 133.52 USD | 5342.66% |
| Guided Therapeutics, Inc. | 1.46 Million USD | 100.477% |
| Ingen Technologies, Inc. | 630.91 Thousand USD | 101.109% |
| Odyssey Group International, Inc. | 2.1 Million USD | 100.332% |
| United American Healthcare Corporation | -9.32 Million USD | 99.925% |
| ECGI Holdings, Inc. | 3.17 Million USD | 100.221% |
| Capital Group Holdings, Inc. | -3508.00 USD | -99.544% |
| ADM Tronics Unlimited, Inc. | 262.61 Thousand USD | 102.665% |
| Urologix, Inc. | 4.61 Million USD | 100.152% |
| Rapid Therapeutic Science Laboratories, Inc. | 4.2 Million USD | 100.166% |
| Nexeon MedSystems Inc. | 3.33 Million USD | 100.21% |
| SS Innovations International, Inc. | 1.18 Million USD | 100.591% |
| Qualis Innovations, Inc. | 6671.00 USD | 204.932% |
| Smith & Nephew plc | 2.77 Billion USD | 100.0% |
| NIOX Group Plc | -23.93 Million USD | 99.971% |
| Fuse Medical, Inc. | 1.75 Million USD | 100.399% |
| Broncus Holding Corporation | -81.42 Million USD | 99.991% |
| Brain Scientific Inc. | 2.11 Million USD | 100.331% |
| Pressure BioSciences, Inc. | 22.67 Million USD | 100.031% |
| Health Logic Interactive Inc. | 39.55 Thousand USD | 117.696% |